Almost all ALT+ cancer cells exhibit loss of the ATRX gene and/or its interaction partner DAXX (15–17), however, the precise role of ATRX/DAXX loss in the initiation and maintenance of ALT remains unclear. Here, ATRX is linked to cancer.